We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPOR
1026
DELISTED
Gulfport Energy Corp.
GPOR
| $4.8M | 0.01% |
279,523
+64,245
| +30% | +$1.23M |
|
1027
Darling Ingredients
DAR
$9.69B
| $4.78M | 0.01% |
329,475
+86,536
| +36% | +$1.14M |
|
1028
Commault Systems
CVLT
$4.82B
| $4.78M | 0.01% |
94,078
+1,618
| +2% | +$82.6K |
|
1029
Guidewire Software
GWRE
$12.8B
| $4.78M | 0.01% |
84,840
+2,771
| +3% | +$151K |
|
|
KNGT
1030
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $4.78M | 0.01% |
152,419
+35,751
| +31% | +$1.12M |
|
|
AKS
1031
DELISTED
AK Steel Holding Corp
AKS
| $4.76M | 0.01% |
662,580
+227,164
| +52% | +$1.95M |
|
1032
Neurocrine Biosciences
NBIX
$18.7B
| $4.76M | 0.01% |
109,854
+2,634
| +2% | +$113K |
|
|
FNGN
1033
DELISTED
Financial Engines, Inc.
FNGN
| $4.75M | 0.01% |
109,141
+34,287
| +46% | +$1.37M |
|
1034
iShares Russell Mid-Cap ETF
IWR
$56.1B
| $4.75M | 0.01% |
101,452
+6,236
| +7% | +$289K |
|
|
ESV
1035
DELISTED
Ensco Rowan plc
ESV
| $4.74M | 0.01% |
132,479
+8,648
| +7% | +$351K |
|
|
ROIC
1036
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $4.74M | 0.01% |
225,450
+66,456
| +42% | +$1.4M |
|
1037
National Health Investors
NHI
$3.69B
| $4.74M | 0.01% |
65,234
+3,091
| +5% | +$227K |
|
1038
Pitney Bowes
PBI
$2.46B
| $4.72M | 0.01% |
359,814
+18,140
| +5% | +$256K |
|
1039
MGIC Investment
MTG
$6.25B
| $4.71M | 0.01% |
465,405
+20,169
| +5% | +$212K |
|
1040
LiveRamp
RAMP
$2.3B
| $4.71M | 0.01% |
165,497
+5,424
| +3% | +$151K |
|
1041
ICU Medical
ICUI
$4.21B
| $4.7M | 0.01% |
30,799
+8,790
| +40% | +$1.28M |
|
1042
Children's Place
PLCE
$54.3M
| $4.69M | 0.01% |
39,082
+9,145
| +31% | +$964K |
|
1043
Unifirst Corp
UNF
$5.31B
| $4.69M | 0.01% |
33,151
+8,324
| +34% | +$1.1M |
|
|
CLR
1044
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $4.69M | 0.01% |
103,198
-62
| -0.1% | -$2.92K |
|
1045
UFP Industries
UFPI
$4.87B
| $4.66M | 0.01% |
141,759
+34,803
| +33% | +$1.16M |
|
1046
Commercial Metals
CMC
$7.57B
| $4.65M | 0.01% |
242,887
+9,381
| +4% | +$192K |
|
1047
Coherent
COHR
$48.7B
| $4.64M | 0.01% |
128,778
+31,025
| +32% | +$1.1M |
|
|
BIG
1048
DELISTED
Big Lots, Inc.
BIG
| $4.64M | 0.01% |
95,277
+1,682
| +2% | +$84.8K |
|
|
SGI
1049
Somnigroup International
SGI
$14.1B
| $4.64M | 0.01% |
399,124
-276
| -0.1% | -$3.55K |
|
|
CCP
1050
DELISTED
Care Capital Properties, Inc.
CCP
| $4.62M | 0.01% |
172,019
+11,169
| +7% | +$281K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.